Case Reports in Infectious Diseases
Volume 2020 (2020), Article ID 9727513, 6 pages
https://doi.org/10.1155/2020/9727513

Case Report

Misidentification of Scedosporium boydii Infection as Aspergillosis in a Patient with Chronic Renal Failure

Yuying Jiang,¹ Amira F Gohara,¹ Robert E. Mrak,¹ and Kenneth L. Muldrew1,2

¹Department of Pathology, University of Toledo Medical Center, Toledo, OH 43614, USA
²Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA

Correspondence should be addressed to Kenneth L. Muldrew; muldrew@bcm.edu

Received 16 January 2020; Revised 20 May 2020; Accepted 4 June 2020; Published 24 June 2020

Academic Editor: Gloria Taliani

Copyright © 2020 Yuying Jiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Aspergillosis is a commonly diagnosed fungal infection. Histopathologic examination alone can have diagnostic pitfalls due to the overlapping of fungal morphology. We report a case of Scedosporium boydii infection initially misdiagnosed as aspergillosis. The patient presented to the hospital with shortness of breath and chest and abdominal pain. Laboratory tests revealed leukocytosis and elevated serum liver enzymes, myoglobin and lipase. He died of hypotensive shock and brain abscesses despite antibiotic treatment. Autopsy revealed invasive fungal infection in the heart, thyroid, and brain with presence of 45-degree angled, branching hyphae. The initial diagnosis of aspergillosis was made; however, further molecular studies identified the organism as S. boydii. This report reveals the potential pitfalls of morphologic diagnosis alone; and the necessity of other testing modalities to render an accurate diagnosis which is crucial for appropriate.

1. Introduction

Over the last two decades, there have been an increased number of life-threatening systemic fungal infections due to both pathogenic and opportunistic fungi. High-risk populations include immunocompromised patients (AIDS, transplant, malignancy, and immunosuppressive therapy). One of the most frequently encountered filamentous fungal agents is Aspergillus species. In recent years, other filamentous fungal pathogens have emerged, such as species of Fusarium, Penicillium, Rhizopus, Rhizomucor, Scedosporium boydii (Pseudallescheria boydii), and agents of phaeohyphomycosis [1–3]. Although Aspergillus remains the most common filamentous mold, the differentiation from other emerging filamentous fungal agents is important due to different treatment regimens. For example, innate resistance or erratic susceptibility to amphotericin B is a characteristic of S. boydii [4, 5]. In tissue sections, the characteristic morphologic appearance of the fungal hyphae has been used to help to differentiate Aspergillus and Mucorales. However, morphology is not always specific. Other diagnostic modalities including fungal culture and fungal ribosomal rRNA gene sequencing are necessary for a definitive diagnosis of the causative fungal agent. Here, we report an autopsy case of systemic invasive fungal infection in a patient with chronic renal failure. Blood and lung cultures submitted at the time of autopsy were negative. Microscopic examination of tissue sections showed the presence of 45-degree angle branching fungal elements. Initial autopsy diagnosis was attributed to systemic aspergillosis. Subsequent broad-range fungal PCR and sequence analysis of DNA extracted from paraffin tissue sections revealed S. boydii (P. boydii) as the causative agent of the infection. Differentiation of S. boydii from Aspergillus species is very important for patient management so that the right antifungal agents can be administered.

2. Case Report

The patient was a 53-year-old male who had stage V chronic renal disease and was on hemodialysis. He presented to the emergency department with acute respiratory failure, chest pain, and one week history of worsening abdominal pain, nausea, and vomiting. The patient’s past medical history included coronary artery disease, stage V chronic kidney disease on hemodialysis, hypertension, diabetes mellitus, warm autoimmune hemolytic anemia, hypercholesterolemia, and gout. His past surgical history included two previous coronary artery stent placements, knee surgery, right upper extremity arteriovenous (AV) fistula, and a recent surgery for a new AV fistula in the left upper extremity one month prior to admission. Following admission, the patient was intubated, and initial laboratory tests were remarkable for leukocytosis, elevated liver enzymes with a negative hepatitis panel, and increased myoglobin, lipase, and creatinine. In addition, the patient exhibited azotemia, metabolic disturbance, and mild coagulopathy (Table 1). Chest X-ray showed cardiomegaly. Despite multidrug antibiotic therapy including vancomycin, Primaxin, doxycycline, and micafungin, the patient’s condition continued to worsen, with the white blood cell count increasing from 22,500/mm³ to 61,000/mm³. The patient’s blood pressure dropped precipitously, and he was treated with vasopressive drugs. The patient also had diarrhea; a subsequent colonoscopy was negative. Other laboratory tests were all normal including blood and sputum cultures, serology for CMV, Brucella species, Rickettsia rickettsii, serum alpha-fetal protein, smooth muscle antibody, mitochondrial antibody, antinuclear antibody, and direct Coombs test. With persistent hypotension, the patient developed atrial fibrillation and had decreased responsiveness. A brain CT scan was performed and showed multiple areas of decreased attenuation with focal mass effect and subacute intraparenchymal hemorrhage in the left frontal lobe (Figure 1). The differential diagnosis of the brain lesions included subacute infarcts and tumor metastasis. The patient died 20 days after admission without a definitive diagnosis of infection.

Table 1: Abnormal laboratory test results.

Test
Result
Reference range

WBC
22.5
4–10 thou/mm³

pH
7.36
7.35–7.45

PCO₂
32
35–45 mmHg

HCO₃
18
23–27 mmol/L

Glucose
226
70–100 mg/dL

Sodium
128
136–146 meq/L

Potassium
7.3
3.4–5.2 meq/L

BUN
62
6–21 mg/dL

eGFR
12
>60 ml/min/1.73 sqm

Creatinine
6.1
0.64–1.27 mg/dL

AST
3522
10–39 IU/L

ALT
1986
4–42 IU/L

Myoglobin
235
0–90 ng/ml

Troponin
0.10
0.00–0.04 ng/ml

Lipase
92
6–32 units/L

APTT
37.4
25–35 sec

PT
19.3
12.3–14.8 sec

INR
1.6
0.91–1.14

D-dimer
>20
0.01–0.49 mcg/ml

FSP
>20
<5 mcg/ml

Figure 1: CT scan of the brain showing multiple areas of decreased attenuation in the bilateral occipital lobes and the right parietal lobe (white arrows); subacute intraparenchymal hemorrhage is present in the left frontal lobe (yellow arrow). R, right lateral; L, left lateral.

3. Materials and Methods

3.1. Histopathologic Study

Numerous specimens from different organ systems were taken at the time of autopsy, fixed in 10% formalin and paraffin embedded. Paraffin sections were cut at 5 μm thickness, stained with hematoxylin eosin (HE), Gomori-Grocott’s methenamine silver (GMS), and Gram stains.

3.2. Molecular Identification

Paraffin-embedded tissues from the brain, heart, and thyroid lesions with the microscopic presence of fungal elements were studied. Deparaffinized sections were processed using the QIAamp DNA FFPE Tissue Kit (QIAGEN, Hilden, Germany) for DNA extraction. DNA sequencing for identification was performed by analysis of internal transcribed spacer region 2 (ITS2) and the 28S rRNA gene. Polymerase chain reactions (PCR) were performed using the primer pairs 5.8S-F (GTG AAT CAT CGA RTC TTT GAA C) and 28S-1 R (TAT GCT TAA GTT CAG CGG GTA) and D1/2-R (GGT CCG TGT TTC AAG ACG G) as previously described using 30–160 ng of extracted DNA [5]. The presence of correctly sized products was confirmed by agarose gel electrophoresis. Sequencing reactions were performed using purified PCR products and the primers 5.8S-F and D1/2-R. Sequencing was performed with an Applied Biosystems 3500 Genetic Analyzer (Life Technologies). The resulting sequence (GenBank accession number-KJ020683.1) was analyzed phylogenetically using NCBI GenBank Basic Local Alignment Search Tool (BLASTn) to identify the closest database match to the patient’s sequence.

4. Results

At autopsy, pertinent gross findings included multiple small hemorrhagic skin papules on the chest, severe atherosclerotic coronary artery disease, multiple necrotic nodular lesions in the heart, thyroid, liver, and lung, and multiple hemorrhagic lesions in the brain (Figure 2). Microscopic examination of the lesions in the heart, thyroid, and to a lesser extent in the lung revealed the presence of 45-degree branching fungal hyphae and acute inflammation (Figure 3). In the hemorrhagic brain lesions, fungal balls (mycetomas) were identified with typical morphology of 45-degree branching hyphae spreading horizontally at the periphery and perpendicularly to the center (Figure 4). The necrotic nodular lesions of the liver were without identifiable fungus or other organisms. Skin sections revealed foci of the necrotic debris, and Gram stain and GMS stains were negative. Blood and lung cultures at autopsy were also negative. The cause of the patient’s death was initially attributed to disseminated aspergillosis based on the morphologic characteristics. After the secondary review of the case, sequencing was performed and revealed the organism to be S. boydii.

Figure 2: Autopsy brain. Multiple hemorrhagic necrotic lesions are present in the brain parenchyma including the cerebrum, cerebellum, and brainstem.

Figure 3: The heart and thyroid tissue display mycetomas. Fungal hyphae are spreading at the peripheral of the lesions. The center of the lesions shows prominent inflammation with neutrophilic infiltration and destruction of the cardiac myocytes (upper panel) and thyroid tissue (lower panel).

Figure 4: Active invading mycetoma is present in the occipital lobe, with 45-degree branching hyphae spreading horizontally at the peripheral and perpendicularly to the center.

5. Discussion

S. boydii (previous naming-P. boydii) is a pathogenic species of the ascomycete genus Scedosporium. Members of the genus along with those of Pseudallescheria have been reclassified [6]. Other species include S. auranticum, S. S. dehoogii, S. minutisporum, and S. desertorum. The previously named pathogenic species S. prolificans has been renamed Lomentospora prolificans along with L. inflatum. These species are ubiquitous filamentous fungi present in soil, sewage, and polluted water. S. boydii can colonize airways of patients with existing disease such as poorly draining bronchi or paranasal sinuses, and “fungus ball” formation in preformed cavities is similar to that seen in Aspergillus [5, 7–9]. Infections caused by these organisms can be localized, extended to the surrounding tissues, or disseminated to distant organs by hematogenous spreading. The disseminated form of the disease is mostly seen among immunocompromised patients [8, 10]. Invasive infections of S. boydii in immunocompetent patients are usually caused by traumatic events such as following implantation and penetrating injuries [7, 8, 11]. Several types of infections have been described including pneumonia, arthritis, osteomyelitis, meningitis, brain abscesses, endophthalmitis, and disseminated systemic disease [7, 8, 10]. The diagnosis of Aspergillosis, one of the most frequently diagnosed fungal infections, is usually made by culture and/or evaluation of tissue sections or cytologic specimens. On histopathalogic or cytologic examination, the fungus demonstrates the presence of characteristic, septate fungal hyphae with 45-degree branching and an even diameter of 3–12 µm (average 4.5 µm) [12]. The major differential diagnosis of aspergillosis in surgical and cytologic specimens is mucormycosis which has thicker (5–20 µm) and right-angle branching nonseptate hyphae [12]. In this report, the morphologic appearance of the S. boydii fungal hyphae in tissue sections closely resembles that of Aspergillus species (Figure 5) with 45-degree branching hyphae and an even diameter of 2.3–5.0 µm (average 3.3 µm). Aspergillus seems to have 45-degree alternating side branching, whereas S. boydii shows 45-degree fork-shaped branching hyphae, in this case (Figure 3). However, without culture or a secondary confirmatory test, misdiagnosis of aspergillosis can occur due to unawareness of infrequently occurring S. boydii as a potential pathogen and the close morphologic resemblance of the two organisms. Other uncommon molds can also mimic the appearance of Aspergillus species including Fusarium, Trichoderma, and Paecilomyces species [12]. Culture studies are critical to the diagnosis but when unavailable or inconclusive, sequencing of fungal rRNA genes for identification from surgical specimens is a very useful alternative. Scedosporiosis caused by S. boydii has a high mortality rate and is difficult to treat. Treatment of these infections is especially challenging because of the mold’s resistance to many antifungal agents [13]. Although S. boydii resembles Aspergillus on pathologic examination, it is typically resistant to amphotericin B. Voriconazole has been shown as an effective agent to treat systemic S. boydii infection, while posaconazole shows less activity, and isavuconazole and itraconazole have minimal activity [4, 11–13]. Echinocandins have some degree of activity albeit at 5 to 10 times higher concentration than that used to treat Aspergillus [4]. In summary, this case highlights the importance of circumspection when diagnosing aspergillosis from anatomic pathology specimens based on morphologic characteristics, as therapeutic decisions may be suboptimal and result in added morbidity and mortality in these critically ill patients.

Figure 5: Comparison of fungal elements between two agents, both present with acute-degree branching hyphae. (a, b) Case report patient: Scedosporium boydii shows fork-shaped 45-degree branching hyphae. (c, d) Example Aspergillus patient: fungal hyphae demonstrating 45-degree alternating side branching in a biopsy specimen. Bar = 5 μm.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

References

I. Tammer, K. Tintelnot, R. C. Braun-Dullaeus et al., “Infections due to Pseudallescheria/Scedosporium species in patients with advanced HIV disease—a diagnostic and therapeutic challenge,” International Journal of Infectious Diseases, vol. 15, no. 6, pp. e422–e429, 2011.

B. Satirapoj, P. Ruangkanchanasetr, S. Treewatchareekorn, O. Supasyndh, L. Luesutthiviboon, and T. Supaporn, “Pseudallescheria boydii brain abscess in a renal transplant recipient: first case report in Southeast Asia,” Transplantation Proceedings, vol. 40, no. 7, pp. 2425–2427, 2008.

M. Richardson and C. Lass-Flörl, “Changing epidemiology of systemic fungal infections,” Clinical Microbiology and Infection, vol. 14, no. 4, pp. 5–24, 2008.

F. Lamoth and D. P. Kontoyiannis, “Therapeutic challenges of non-aspergillus invasive mold infections in immunosuppressed patients,” Antimicrobial Agents and Chemotherapy, vol. 63, no. 11, Article ID e01244, 2019.

A. Panackal and K. Marr, “Scedosporium/Pseudallescheria infections,” Seminars in Respiratory and Critical Care Medicine, vol. 25, no. 2, pp. 171–181, 2004.

M. Lackner, G. S. De Hoog, L. Yang et al., “Proposed nomenclature for Pseudallescheria, Scedosporium and related genera,” Fungal Diversity, vol. 67, no. 1, pp. 1–10, 2014.

K. J. Cortez, E. Roilides, F. Quiroz-Telles et al., “Infections caused by Scedosporium spp,” Clinical Microbiology Reviews, vol. 21, no. 1, pp. 157–197, 2008.

A. Ramirez-Garcia, A. Pellon, A. Rementeria et al., “Scedosporium and Lomentospora: an updated overview of underrated opportunists,” Medical Mycology, vol. 56, no. 1, pp. S102–S125, 2018.

T. Gottesman-Yekutieli, M. Dan, O. Shwartz, A. Edelman, and D. Hendel, “Pseudallescheria boydii infection of a prosthetic hip joint-an uncommon infection in a rare location,” The American Journal of the Medical Sciences, vol. 342, no. 3, pp. 250–253, 2011.

J. Guarner and M. E. Brandt, “Histopathologic diagnosis of fungal infections in the 21st century,” Clinical Microbiology Reviews, vol. 24, no. 2, pp. 247–280, 2011.

M. Lackner, G. S. de Hoog, P. E. Verweij et al., “Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 5, pp. 2635–2642, 2012.

L. G. Apostolova, E. K. Johnson, and H. P. Adams, “Disseminated Pseudallescheria boydii infection successfully treated with voriconazole,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 76, no. 12, pp. 1741-1742, 2005.

F. Gilgado, C. Serena, J. Cano, J. Gené, and J. Guarro, “Antifungal susceptibilities of the species of the Pseudallescheria boydii complex,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 12, pp. 4211–4213, 2006.

P. D. Khot, D. L. Ko, and D. N. Fredricks, “Sequencing and analysis of fungal rRNA operons for development of broad-range fungal PCR assays,” Applied and Environmental Microbiology, vol. 75, no. 6, pp. 1559–1565, 2009.

G. Bashir, S. Shakeel, T. Wani, and D. K. Kakru, “Pulmonary pseudallescheriasis in a patient with healed tuberculosis,” Mycopathologia, vol. 158, no. 3, pp. 289–291, 2004.

Y. Jayamohan and J. A. Ribes, “Pseudallescheriasis: a summary of patients from 1980–2003 in a tertiary care center,” Archives of Pathology &amp; Laboratory Medicine, vol. 130, no. 12, pp. 1843–1846, 2006.